Ischaemic stroke in young adults: risk factors and long-term consequences
Noortje A M M Maaijwee1, Loes C A Rutten-Jacobs1, Pauline Schaapsmeerders1
1Department of Neurology, Radboud University Nijmegen Medical Centre, Donders Institute for Brain, Cognition and Behaviour, Centre for Neuroscience, PO Box 9101, 6500 HB, Nijmegen, Netherlands.
Insights
The average age of ischemic stroke onset is decreasing, with more young individuals affected. Traditional vascular risk factors are rising in this group, necessitating lifelong secondary prevention strategies.
Area of Science:
- Neurology
- Cardiovascular Medicine
- Public Health
Background:
- Ischemic stroke incidence is rising in individuals under 50 years old, contrary to trends in other diseases.
- Traditional vascular risk factors are increasingly prevalent in younger populations, shifting the etiological landscape.
- Young stroke survivors face unique challenges due to their long life expectancy and life stage.
Purpose of the Study:
- To provide a critical overview of risk factors and etiology for young ischemic stroke.
- To address the long-term prognosis, including cardiovascular risk, functional outcomes, and psychosocial consequences.
- To highlight the need for new research and clinical trials focused on this demographic.
Main Methods:
- Review of existing literature on young ischemic stroke.
- Analysis of risk factor trends and etiological shifts.
- Evaluation of long-term prognosis data and patient outcomes.
Main Results:
- The role of rare risk factors is diminishing, while traditional vascular risk factors are increasingly implicated in young stroke.
- Long-term prognosis for young stroke survivors is less favorable than previously assumed, impacting mortality, cardiovascular disease, and psychosocial well-being.
- Poor functional outcomes and psychosocial problems are prevalent, requiring further investigation and optimized interventions.
Conclusions:
- Secondary stroke prevention is a lifelong commitment for most young stroke survivors.
- New randomized trials are essential to confirm the benefits of long-term secondary preventive medication in young patients.
- Further research is needed to optimize treatment and rehabilitation strategies for young stroke survivors, addressing functional and psychosocial deficits.
Abstract:
Contrary to trends in most other diseases, the average age of ischaemic stroke onset is decreasing, owing to a rise in the incidence of stroke among 'young' individuals (under 50 years of age). This Review provides a critical overview of the risk factors and aetiology of young ischaemic stroke and addresses its long-term prognosis, including cardiovascular risk, functional outcome and psychosocial consequences. We highlight the diminishing role of 'rare' risk factors in the pathophysiology of young stroke in light of the rising prevalence of 'traditional' vascular risk factors in younger age groups. Long-term prognosis is of particular interest to young patients, because of their long life expectancy and major responsibilities during a demanding phase of life. The prognosis of young stroke is not as favourable as previously thought, with respect either to mortality or cardiovascular disease or to psychosocial consequences. Therefore, secondary stroke prevention is probably a life-long endeavour in most young stroke survivors. Due to under-representation of young patients in past trials, new randomized trials focusing on this age group are needed to confirm the benefits of long-term secondary preventive medication. The high prevalence of poor functional outcome and psychosocial problems warrants further study to optimize treatment and rehabilitation for these young patients.
Related Concept Videos
Ischemic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology
Hemorrhagic Stroke l: Introduction
Stroke: Introduction and Types
Transient Ischemic Attack l: Introduction
Hemorrhagic Stroke ll: Pathophysiology


